|
Volumn 86, Issue 1, 2001, Pages 1-3
|
I: Can we characterize the central nervous system actions of α2-adrenergic agonists?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINE;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
CENTRAL DEPRESSANT AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLONIDINE;
DEXMEDETOMIDINE;
DIAZEPAM;
IDAZOXAN;
NEOSTIGMINE;
NORADRENALIN;
OPIATE;
PLACEBO;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ANALGESIC AGENT;
HYPNOTIC SEDATIVE AGENT;
ACETYLCHOLINE RELEASE;
ANALGESIA;
ANESTHESIA;
AROUSAL;
BRADYCARDIA;
BRAIN REGION;
CENTRAL NERVOUS SYSTEM;
CONTROLLED STUDY;
DESENSITIZATION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENTIATION;
EDITORIAL;
HUMAN;
HYPERTENSION;
INTENSIVE CARE;
NONHUMAN;
NORADRENALIN RELEASE;
PATIENT MONITORING;
PRIORITY JOURNAL;
PSYCHOMOTOR PERFORMANCE;
REBOUND;
SEDATION;
TRANQUILIZING ACTIVITY;
WITHDRAWAL SYNDROME;
XEROSTOMIA;
BRAIN;
METHODOLOGY;
ADRENERGIC ALPHA-AGONISTS;
ANALGESICS;
BRAIN;
CLONIDINE;
HUMANS;
HYPNOTICS AND SEDATIVES;
INTENSIVE CARE;
|
EID: 0034747173
PISSN: 00070912
EISSN: None
Source Type: Journal
DOI: 10.1093/bja/86.1.1 Document Type: Editorial |
Times cited : (11)
|
References (23)
|